Manuel R. Estioko, MD is a Cardiac Surgeon from Los Angeles, California. He first developed an interest and involvement in Bloodless Surgery because of the very high incidence of Hepatitis C in open heart patients (18 % in New York City). At that time (late 1960’s & 1970):
In 1996, Dr. Estioko coined and popularized the term “Transfusion Free Surgery” which is the other widely used designation for Bloodless Surgery.
All the patients in this report declined blood transfusion by reason of their religion; they were Jehovah’s Witnesses. Their decision was Bible-based and was not negotiable. The five major blood products that were not acceptable included: whole blood, plasma, red blood cells, white blood cells and platelets. Minor blood fractions, like coagulation factors, were considered a matter of conscience and most of the patients accepted them. Special informed consent forms were signed and witnessed. Face- to-face discussions between patient and surgeon were held two times or more. A close member or members of the family were encouraged to join in and all questions were answered to the patient’s satisfaction. These patients were well informed, most cooperative and very grateful.
The surgeon agreed to treat the patients with the above blood restriction. All the members of the surgical team including the anesthesiologist had agreed to this and all were committed to the goal of surgery without blood transfusion. The surgeon provides strong leadership (captain of the ship) since he has the ultimate responsibility to the patient.
Cardiac surgery without blood transfusion was viewed as a total management approach that involves the three phases of care: preoperative, intraoperative, and postoperative.
Anemia is the most important single predictor of blood transfusion in surgery. The additional blood loss during surgery worsens the anemia. None of our patients had preoperative anemia, all had normal levels of hemoglobin and hematocrit.
Limiting blood loss during surgery is mainly related to meticulous surgical technique and therefore this job is the primary responsibility of the surgeon. The technique is characterized by surgical precision and efficiency (no delays or wasted motions) while doing the operation with careful hemostasis during every step of the procedure. When this is practiced every time, it becomes a second nature to the surgeon and actually shortens the operative time. Good exposure and visualization are essential. All bleeders and potential bleeding situations are cared for without allowing anything to chance. Particular care is directed to working in the back of the heart where the exposure may be limited. Recheck and control of bleeders are performed while the patient is still on bypass and/or before decannulation. Lifting the heart to look for a bleeder at the end of the procedure may cause hemodynamic instability in the recovering heart. The “method is everything” which means details and more details. Here, experience makes a difference.
In preparation for the operation, the surgeon reviews the X-rays and CT scan of the chest (preferably a 64-slice scan) to evaluate the proximity of the heart to the sternal bone and plan his surgical approach in cutting the bone and dissecting the heart. The surgeon figures out the anatomic considerations by correlating the patient’s chest anatomy. As previously mentioned, the heart is often adhered intimately to the sternum, so care should be exercised and more so in the presence of an enlarged heart. A semi-circular blade electric saw is used very carefully. Once the bone is cut, one side of the bone at a time is now lifted gradually and dissection of the cardiac structures is done patiently with utmost care. Enough dissection is carried out to be able to:
It is not necessary to free the whole heart. To avoid bleeding when there is a truly difficult area of exposure, cardiopulmary bypass maybe started as an option for safety. On the other hand, too early start of the bypass prolongs bypass time, which is not desirable.
Cardiopulmonary bypass supports the entire patient during the period when the actual work in the heart is being done. The system is efficient to maintain controlled flow, adequate pressure and perfusion to the tissues of the body with optimum oxygenation. To fulfill these requirements, the bypass system we use has the following features:
The small total prime volume avoids excessive hemodilution. An experienced and knowledgeable perfusion team is an essential part of the team.
Myocardial protection: One of the greatest advances in cardiac surgery in recent years is in the improvement of myocardial protection with use of cold Potassium (K) cardioplegia. This prevents heart muscle injury during the anoxic period of the operation (aortic cross clamp). At this time, the heart muscle is not getting the usual flow of blood and oxygen. Good myocardial protection allows safe operation since the heart recovers well even with the patients with very poor cardiac function with low ejection fraction (EF). The cardioplegia we use, called Microplegia using the Quest Myocardial Protection System (Quest MPS, Atron Corporation, Allen, Texas), has unique advantages: it provides excellent myocardial protection as well as good control of hemodilution. Essentially, Microplegia consists of cold solution of small volume high concentration of K delivered using the fluid from the bypass circuit as the vehicle. The Microplegia is delivered antegrade via the coronary arteries and retrograde via the coronary sinus about every 15 minutes. One important detail that ensures good perfusion of the myocardium is to monitor the retrograde coronary perfusion pressure, which is maintained at 30-40 mm Hg.
Total microplegia fluid infusion throughout the whole operation is only about 100 to 150 ml, because the diluent for the very high K concentration used is coming from the cardiopulmonary circuit, made possible by the highly sophisticated mixing function and pump delivery of the Quest MPS. Therefore, no additional fluid is needed, which is a novel idea. In contrast, the standard/conventional way of using cardioplegia by most cardiac surgeons involves using cardioplegia solutions prepared beforehand in one- liter bottles of saline solution with a small dose of Potassium; about three to five liters (1000 ml per bottle) are given for myocardial protection, further aggravating the hemodilution, with adverse effect on the patient’s coagulation function (highly diluted blood does not clot well).
Avoiding coagulopathy is a complex subject and is not well understood by many. There is a basic and fundamental biological truth that has to be considered at all times, that is, the human blood is meant to be in its natural environment inside the blood vessels which have a surface lining that is biologically active and friendly to the blood. This lining promotes smooth flow as blood travels through the vessels throughout the entire circulatory system. Once the blood is exposed outside to foreign surfaces there are abnormal changes and degradations to its elements affecting its functions. The use of cardiopulmonary, pumps, tubings, cell savers, suctions, other invasive procedures do just that. Therefore, the less and shorter we use these, the better for the blood. It is important to understand the specific factors during surgery that may contribute to bleeding problem and should be avoided. The following should be avoided and some solutions are suggested:
If you follow the above suggestions, you will achieve superior outcomes. This approach enables the surgeon to avoid the faulty thinking or habits epitomized by the philosophy: “Do not worry about the fluids, we can do hemococentration,” or “Do not worry about those bleeders, the cell saver will take care of it.”
The anesthesiologist is the other vital player in the OR who works closely with the surgeon and the perfusion team. He is responsible for hemodynamic monitoring and oxygenation throughout the course of the operation. He puts in the monitoring lines, which include arterial line, central venous line (CVP), and Swan-Ganz catheter prior to induction of anesthesia and endotracheal intubation. He also performs transesophageal echocardiogram (TEE) at certain parts of the operation to evaluate cardiac function and verifies the position of the coronary sinus catheter that monitors the pressure during retrograde cardioplegia delivery. In addition, he administers necessary fluids, drugs like Heparin, and later Protamine, and other needed cardiovascular medications
The anesthesiologist, surgeon, perfusionist and nurses must communicate well throughout the course of the operation especially on issues of monitoring, hemodynamic parameters, oxygenation, volume/fluids and drug use.
One other procedure requiring the anesthesiologist to be skilled in bloodless techniques is the practice of acute normovolemic hemodilution (ANH). The anesthesiologist removes a unit or two units of blood (calculated amount depending on the patient) in a proper storage bag prior to Heparin and cardiopulmonary bypass. The removed blood is kept in continuity with the patient’s cardiopulmonary bypass circuit, but not in continuous flow; it has all the coagulation factors intact. It is returned to the patient at the end of the operation for improved hemostatic function. In addition, the returned blood increases the patient’s hemoglobin and hematocrit. This is a very important procedure, when property utilized, in the overall strategy for avoiding blood transfusion.
It is desirable to keep lower BP by using drugs during the periods of sternotomy and cardiopulmonary bypass cannulation. There is some blood loss during at these maneuvers, which can be decreased by keeping the patient’s BP down. The anesthesiologist must control the systolic BP to about 100 mm of Hg during these periods.
Antifibrinolytic Agents: Antifibrinolytic agents are suggested to help improve hemostasis and decrease bleeding using tranexamic acid or aminocaproic acid (Amicar) with similar efficacy. In the past, Aprotinin (Trasylol) had been used but this drug has been discontinued by the Food and Drug Administration (FDA) because of reports of associated increased in mortality and renal dysfunction (Bayer Corporation withdrew the drug in 2008).
It is important to know the location of a patent Internal Mammary Graft (IMA) to avoid its injury during the reoperation. A CT angiogram and preoperative selective angiogram localize the IMA and show the proximity to the sternum. The IMA should not be injured because it is important to the blood supply to the heart and can also cause bleeding. The surgeon plans and executes his surgical approach accordingly to avoid this problem.
Plan the steps of the operation, avoid unnecessary dissection but with enough good surgical exposure. Practice proper sequencing technique which means doing a step and going to the next seamlessly with efficiency without pausing to admire your work. This helps in cutting down the operative time. Be sure that the valve is properly sized to avoid mismatch. The sutures are precisely placed, the valve is seated properly and the sutures are tied tightly. All suture lines are rechecked several times. Hemostatic glues and sealants may be utilized and were used in some of our patients.
For purposes of Illustration, Here Are Examples of Good Hemostasis
Photo Courtesy of Shannon Farmer
Photo Courtesy of Sharo Raissi, MD
When preoperative and intraoperative care have been properly executed there is minimum blood loss, no bleeding, and the Hb/ Hematocrit levels are adequate at the end of the operation. The recovery will be smooth without any problem. The next step is to pay attention to the details of postoperative care. Precise postoperative Intensive Care Unit (ICU) monitoring with stabilization of the patient are most important. Proper setup and a well-trained nursing staff are must requirements. The arterial BP should be maintained not higher than about 110 mm Hg systolic after surgery. Hypertension can potentially start bleeding at the operative sites or suture lines. This has to be avoided by sedation and using vasodilators as needed including using Nitroprusside drip which maybe started in the OR and during transport to the ICU. Chest tube drainage should be watched carefully. It is usually less than 100 ml/ hour. Any drainage of more than 100 ml in the next 2 to 3 hours after surgery is a concern. Early exploration for bleeding is entertained to control bleeding. No patient in this series required exploration for bleeding.
There is wisdom in the practice of sedating the patient and waiting for about four hours prior to considering endotracheal extubation. By this time, the patient stabilizes hemodynamically and it can be ascertained that there is no bleeding. With satisfactory parameters of cardiac index, pulmonary diastolic pressure and good urinary output, sedation is discontinued, the team can proceed with ventilation weaning and endotracheal extubation according to protocol.
Since these operations were done in a span of several years, the surgical technique has undergone some adjustments to “fine-tune” things and adopt new things that work better. The sound medical and surgical principles however did not change much. To avoid blood loss, meticulous and precise surgical technique remains the most important. By carefully following this total management approach and carefully adhering to sound surgical principles and techniques as suggested here, redo-cardiac surgery can be performed safely and successfully without blood transfusion. Note that the one death in this report was in the early experience.
It may be difficult to duplicate this single-surgeon experience; however it is a testimony that it can be done successfully. A surgeon who wishes to attempt this undertaking should not be take it lightly. He has to believe that this can be done and then commit to do it by applying all his talents and skills. It is recommended to start with the primary operations, and try to do many of them well, which builds confidence for the next step to doing the redo-operations. The surgeon should assemble an A- team whose members are also committed to the goal. A positive attitude for success is a desirable virtue.
Learn how you can implement a bloodless program in your institution.
Learn more about bloodless medicine and surgery.